Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “dTap Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Large-scale testing (Phase 3)Study completedNCT01411241
What this trial is testing

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

Who this might be right for
DengueDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 720
Post-approval studies (Phase 4)Study completedNCT02526394
What this trial is testing

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

Who this might be right for
PertussisMeningitisPreventive Immunization; Meningitis+1 more
Public Health England 400
Testing effectiveness (Phase 2)Study completedNCT00338351
What this trial is testing

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Who this might be right for
Hepatitis A
GlaxoSmithKline 240
Post-approval studies (Phase 4)Study completedNCT04543669
What this trial is testing

Adacel® Booster Vaccination for CMI Assay Development

Who this might be right for
Pertussis
Dalhousie University 10
Large-scale testing (Phase 3)Study completedNCT00586612
What this trial is testing

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 313
Large-scale testing (Phase 3)Study completedNCT01444781
What this trial is testing

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi Pasteur, a Sanofi Company 1,106
Not applicableStudy completedNCT02610348
What this trial is testing

Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of Age

Who this might be right for
Hepatitis B
Sanofi Pasteur, a Sanofi Company 122
Post-approval studies (Phase 4)Study completedNCT02052661
What this trial is testing

This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa

Who this might be right for
Hepatitis B
GlaxoSmithKline 301
Not applicableStudy completedNCT01929291
What this trial is testing

Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

Who this might be right for
Diphtheria-Tetanus-acellular Pertussis Vaccines
GlaxoSmithKline 682
Post-approval studies (Phase 4)Study completedNCT00289913
What this trial is testing

Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)

Who this might be right for
Hepatitis A Virus
Merck Sharp & Dohme LLC 1,274
Large-scale testing (Phase 3)Study completedNCT00432042
What this trial is testing

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Who this might be right for
VaricellaMeaslesMumps+7 more
Merck Sharp & Dohme LLC 955
Large-scale testing (Phase 3)Study completedNCT00355654
What this trial is testing

Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®

Who this might be right for
InfantHealthy
Sanofi Pasteur, a Sanofi Company 847
Not applicableStudy completedNCT00258882
What this trial is testing

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

Who this might be right for
Pertussis
Sanofi Pasteur, a Sanofi Company 327,293
Not applicableStudy completedNCT00524732
What this trial is testing

Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age

Who this might be right for
PertussisDiphtheria
Sanofi Pasteur, a Sanofi Company 7,156
Post-approval studies (Phase 4)Study completedNCT00802867
What this trial is testing

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 989
Not applicableStudy completedNCT00297856
What this trial is testing

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Who this might be right for
DiphtheriaTetanusAcellular Pertussis
GlaxoSmithKline 10,000
Not applicableStudy completedNCT03142139
What this trial is testing

Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?

Who this might be right for
Atopic Dermatitis
Bandim Health Project 1,027,559
Large-scale testing (Phase 3)Study completedNCT01767376
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 692
Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Next Page